4//SEC Filing
Parschauer Karah Herdman 4
Accession 0001677455-25-000005
CIK 0001515673other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 4:11 PM ET
Size
4.8 KB
Accession
0001677455-25-000005
Insider Transaction Report
Form 4
Parschauer Karah Herdman
EVP and Chief Legal Officer
Transactions
- Sale
Common Stock
2025-09-12$31.17/sh−2,450$76,367→ 73,271 total
Footnotes (2)
- [F1]Includes 434 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on April 30, 2025.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001677455
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 4:11 PM ET
- Size
- 4.8 KB